Tumor vaccines for breast cancer.
Anderson
Karen S
KS
Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
D000818:Animals; D000917:Antibody Formation; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007115:Immunization Schedule; D007156:Immunologic Memory; D018396:Mucin-1 / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D019098:Telomerase / Q000276:immunology; D014611:Vaccination
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines; D018396:Mucin-1; D018719:Erb-b2 Receptor Tyrosine Kinases; D019098:Telomerase; C509186:TERT protein, human